Evidence-based prescribing for post-traumatic stress disorder

Bisson, Jonathan ORCID: https://orcid.org/0000-0001-5170-1243, Baker, Amy, Dekker, William and Hoskins, Mathew 2020. Evidence-based prescribing for post-traumatic stress disorder. British Journal of Psychiatry 216 (3) , pp. 125-126. 10.1192/bjp.2020.40

PDF - Accepted Post-Print Version Download (175kB)

Abstract

There is strong research evidence to support the pharmacological treatment of post-traumatic stress disorder (PTSD) as a second line to trauma-focused psychological interventions. Fluoxetine, paroxetine, sertraline and venlafaxine are the best-evidenced drugs, with lower-level evidence for other medications. It is important that prescribing for PTSD is evidence-based.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Royal College of Psychiatrists
ISSN:	0007-1250
Date of First Compliant Deposit:	23 January 2020
Date of Acceptance:	17 January 2020
Last Modified:	17 Nov 2024 04:30
URI:	https://orca.cardiff.ac.uk/id/eprint/128956

Citation Data

Cited 9 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item